Placebo for glimepiride

DRUG2 trials

Sponsors

AstraZeneca, Theracos

Conditions

Inadequate Glycaemic ControlType 2 Diabetes Mellitus

Phase 3

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

CompletedNCT02769481

TheracosType 2 Diabetes Mellitus

Start: 2016-08-15End: 2019-06-14Updated: 2021-05-27

Phase 4

Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

CompletedNCT02471404

AstraZenecaInadequate Glycaemic Control, Type 2 Diabetes Mellitus

Start: 2015-09-21End: 2017-03-13Updated: 2019-03-26

Related Papers

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes.

2018-07-1648 citations